Back to Search
Start Over
US FDA accepts NDA to review Seysara for treatment of moderate to severe acne
- Source :
- PharmaBiz. December 22, 2017
- Publication Year :
- 2017
-
Abstract
- Allergan plc, a leading global pharmaceutical company, and Paratek Pharmaceuticals, a biopharmaceutical company focused on the development and commercialization of therapies based upon tetracycline chemistry, announced that the US Food [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- PharmaBiz
- Publication Type :
- Periodical
- Accession number :
- edsgcl.519912951